346 related articles for article (PubMed ID: 35304847)
1. Non-communicable diseases in older people living with HIV in four African countries: a cohort study.
Chang D; Esber A; Dear N; Iroezindu M; Bahemana E; Kibuuka H; Owuoth J; Maswai J; Crowell T; Polyak C; Cavanaugh JS; Ake JA; Godfrey C
Lancet HIV; 2022 Mar; 9 Suppl 1():S5. PubMed ID: 35304847
[TBL] [Abstract][Full Text] [Related]
2. Non-communicable diseases by age strata in people living with and without HIV in four African countries.
Chang D; Esber AL; Dear NF; Iroezindu M; Bahemana E; Kibuuka H; Owuoth J; Maswai J; Crowell TA; Polyak CS; Cavanaugh JS; Ake JA; Godfrey C;
J Int AIDS Soc; 2022 Sep; 25 Suppl 4(Suppl 4):e25985. PubMed ID: 36176018
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa.
van Heerden A; Barnabas RV; Norris SA; Micklesfield LK; van Rooyen H; Celum C
J Int AIDS Soc; 2017 Oct; 20(2):. PubMed ID: 29064168
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda.
Kavishe B; Biraro S; Baisley K; Vanobberghen F; Kapiga S; Munderi P; Smeeth L; Peck R; Mghamba J; Mutungi G; Ikoona E; Levin J; Bou Monclús MA; Katende D; Kisanga E; Hayes R; Grosskurth H
BMC Med; 2015 May; 13():126. PubMed ID: 26021319
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe.
Gonah L; Moodley I; Hlongwana K
Afr J Prim Health Care Fam Med; 2020 Aug; 12(1):e1-e6. PubMed ID: 32787407
[TBL] [Abstract][Full Text] [Related]
6. Non-communicable diseases and related risk behaviors among men and women living with HIV in Cambodia: findings from a cross-sectional study.
Chhoun P; Ngin C; Tuot S; Pal K; Steel M; Dionisio J; Pearson H; Mburu G; Brody C; Yi S
Int J Equity Health; 2017 Jul; 16(1):125. PubMed ID: 28705242
[TBL] [Abstract][Full Text] [Related]
7. Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013.
Achwoka D; Waruru A; Chen TH; Masamaro K; Ngugi E; Kimani M; Mukui I; Oyugi JO; Mutave R; Achia T; Katana A; Ng'ang'a L; De Cock KM
BMC Public Health; 2019 Apr; 19(1):372. PubMed ID: 30943975
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda.
Kansiime S; Mwesigire D; Mugerwa H
PLoS One; 2019; 14(8):e0221022. PubMed ID: 31398244
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and determinants of non-communicable diseases including depression among HIV patients on antiretroviral therapy in Dar es Salaam, Tanzania.
Mutagonda RF; Siril H; Kaaya S; Amborose T; Haruna T; Mhalu A; Urassa D; Mtisi E; Moshiro C; Tarimo E; Mahiti GR; Minja A; Somba M; August F; Mugusi F
Trop Med Int Health; 2022 Aug; 27(8):742-751. PubMed ID: 35687423
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of cardiovascular risk factors by HIV status in a population-based cohort in South Central Uganda: a cross-sectional survey.
Enriquez R; Ssekubugu R; Ndyanabo A; Marrone G; Gigante B; Chang LW; Reynolds SJ; Nalugoda F; Ekstrom AM; Sewankambo NK; Serwadda DM; Nordenstedt H
J Int AIDS Soc; 2022 Apr; 25(4):e25901. PubMed ID: 35419976
[TBL] [Abstract][Full Text] [Related]
11. Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America.
Belaunzaran-Zamudio PF; Caro-Vega Y; Giganti MJ; Castilho JL; Crabtree-Ramirez BE; Shepherd BE; Mejía F; Cesar C; Moreira RC; Wolff M; Pape JW; Padgett D; McGowan CC; Sierra-Madero JG;
PLoS One; 2020; 15(6):e0233965. PubMed ID: 32555607
[TBL] [Abstract][Full Text] [Related]
12. Burden of cumulative risk factors associated with non-communicable diseases among adults in Uganda: evidence from a national baseline survey.
Wesonga R; Guwatudde D; Bahendeka SK; Mutungi G; Nabugoomu F; Muwonge J
Int J Equity Health; 2016 Dec; 15(1):195. PubMed ID: 27905949
[TBL] [Abstract][Full Text] [Related]
13. Incidence of non-communicable diseases (NCDs) in HIV patients on ART in a developing country: Case of Zimbabwe's Chitungwiza Central Hospital-A retrospective cohort study (2010-2019).
Cheza A; Tlou B; Zhou DT
PLoS One; 2021; 16(5):e0252180. PubMed ID: 34043718
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of non-communicable diseases among key populations enrolled at a large HIV prevention & treatment program in Kenya.
Achwoka D; Oyugi JO; Mutave R; Munywoki P; Achia T; Akolo M; Muriuki F; Muthui M; Kimani J
PLoS One; 2020; 15(7):e0235606. PubMed ID: 32614906
[TBL] [Abstract][Full Text] [Related]
15. Noninfectious Comorbidity in the African Cohort Study.
Ake JA; Polyak CS; Crowell TA; Kiweewa F; Semwogerere M; Maganga L; Bahemana E; Maswai J; Langat R; Owuoth J; Otieno S; Keshinro B; Esber AL; Liu M; Eller LA; Ganesan K; Parikh AP; Hamm TE; Robb ML; Hickey PW; Valcour VG; Michael NL;
Clin Infect Dis; 2019 Aug; 69(4):639-647. PubMed ID: 30476001
[TBL] [Abstract][Full Text] [Related]
16. Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil.
Castilho JL; Escuder MM; Veloso V; Gomes JO; Jayathilake K; Ribeiro S; Souza RA; Ikeda ML; de Alencastro PR; Tupinanbas U; Brites C; McGowan CC; Grangeiro A; Grinsztejn B
J Int AIDS Soc; 2019 Jan; 22(1):e25233. PubMed ID: 30697950
[TBL] [Abstract][Full Text] [Related]
17. Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study.
Ahmadi A; Shirani M; Khaledifar A; Hashemzadeh M; Solati K; Kheiri S; Sadeghi M; Mohammadian-Hafshejani A; Shahraki HR; Asgharzadeh A; Salehifard AZ; Mousavi M; Zarean E; Goujani R; Nazari SSH; Poustchi H; Dugué PA
BMC Public Health; 2021 Dec; 21(1):2275. PubMed ID: 34903205
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda.
Sando D; Kintu A; Okello S; Kawungezi PC; Guwatudde D; Mutungi G; Muyindike W; Menzies NA; Danaei G; Verguet S
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25507. PubMed ID: 32562364
[TBL] [Abstract][Full Text] [Related]
19. Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective.
Kasaie P; Weir B; Schnure M; Dun C; Pennington J; Teng Y; Wamai R; Mutai K; Dowdy D; Beyrer C
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25499. PubMed ID: 32562353
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda.
Byonanebye DM; Polizzotto MN; Parkes-Ratanshi R; Musaazi J; Petoumenos K; Castelnuovo B
PLoS One; 2023; 18(2):e0282001. PubMed ID: 36800379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
